Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  2,490 results for ""INTERLEUKIN-2""

Your Filters

Subject : hiv infections
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.

  • Authors : Gupta A; Molecular Pathology Group, Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Subjects: CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/immunology ; HIV Infections*/HIV Infections*/HIV Infections*/immunology ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: Journal of medical virology [J Med Virol] 2024 Aug; Vol. 96 (8), pp. e29820.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

Read More Add to Saved list
×
Academic Journal

Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.

  • Authors : Miller JS; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Rhein J

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; HIV Infections*/HIV Infections*/HIV Infections*/immunology ; HIV Infections*/HIV Infections*/HIV Infections*/virology

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 May 15; Vol. 229 (5), pp. 1256-1265.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

HIV-1 Transcriptional Activator Tat Inhibits IL2 Expression by Preventing the Presence of Pol II on the IL2 Promoter.

  • Authors : Anastasopoulou S; Laboratory of Immunohematology, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, GR-26500 Patras, Greece.; Georgakopoulos T

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/genetics ; HIV Infections*/HIV Infections*/HIV Infections*/immunology ; HIV Infections*/HIV Infections*/HIV Infections*/virology

  • Source: Biomolecules [Biomolecules] 2023 May 24; Vol. 13 (6). Date of Electronic Publication: 2023 May 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

Read More Add to Saved list
×
Academic Journal

Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.

  • Authors : Singh H; Department of Molecular Biology, National AIDS Research Institute Pune- 411026, India.; Nambiar N

Subjects: Genetic Predisposition to Disease* ; Polymorphism, Single Nucleotide* ; Promoter Regions, Genetic*

  • Source: Current molecular medicine [Curr Mol Med] 2019; Vol. 19 (3), pp. 206-215.Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101093076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Transforming Growth Factor-β Suppresses Interleukin (IL)-2 and IL-1β Production in HIV-Tuberculosis Co-Infection.

  • Authors : Devalraju KP; 1 Department of Immunology and Molecular Biology, Bhagwan Mahavir Medical Research Centre, Hyderabad, India.; Neela VSK

Subjects: HIV Infections/HIV Infections/HIV Infections/*immunology ; Interleukin-1beta/Interleukin-1beta/Interleukin-1beta/*antagonists & inhibitors ; Interleukin-2/Interleukin-2/Interleukin-2/*antagonists & inhibitors

  • Source: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2019 Jun; Vol. 39 (6), pp. Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9507088 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.

  • Authors : de Lastours V; Department of Infectious Diseases, Saint-Louis Hospital, Paris, France; University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Subjects: HIV-1*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Burkitt Lymphoma/Burkitt Lymphoma/Burkitt Lymphoma/*virology

  • Source: HIV medicine [HIV Med] 2014 Jan; Vol. 15 (1), pp. 23-9. Date of Electronic Publication: 2013 Sep 06.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read Online Read More Add to Saved list
×
Academic Journal

[Treatment of HIV infections with antiretroviral drugs and recombinant interleukin-2].

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; Interleukin-2/Interleukin-2/Interleukin-2/*administration & dosage

  • Source: Ugeskrift for laeger [Ugeskr Laeger] 2000 Oct 16; Vol. 162 (42), pp. 5614-8.Publisher: Den Alm Danske Laegerforening Country of Publication: Denmark NLM ID: 0141730 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Report

Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection.

Subjects: HIV-1* ; Immunocompromised Host*; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: Emerging infectious diseases [Emerg Infect Dis] 2015 Sep; Vol. 21 (9), pp. 1685-7.Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/*metabolism ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: AIDS (London, England) [AIDS] 2012 Mar 27; Vol. 26 (6), pp. 711-20.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine.

  • Authors : Brezar V; Inserm, U955, Equipe 16, Créteil, Paris, France.; Université Paris Est, Faculté de médecine, Créteil, Paris, France.

Subjects: AIDS Vaccines/AIDS Vaccines/AIDS Vaccines/*administration & dosage ; Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; HIV Infections/HIV Infections/HIV Infections/*immunology

  • Source: PLoS pathogens [PLoS Pathog] 2017 Jul 14; Vol. 13 (7), pp. e1006489. Date of Electronic Publication: 2017 Jul 14 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  2,490 results for ""INTERLEUKIN-2""